The Hallas-Møller Emerging Investigator – Bioscience and Basic Biomedicine is a funding scheme from the Novo Nordisk Foundation and supports highly promising new group leaders with novel and ambitious projects that will bring new and important insight into life and health. Applicants should have a maximum of 2-3 years of group leader experience at the time of the project start. Applicants must, during the project, be employed and have their research group in Denmark, and the project must be anchored at a university, hospital, or other non-profit research institution in Denmark. This grant also supports the international recruitment of talented new group leaders in bioscience and basic biomedicine to Denmark. The Grant provides 10 million DKK. Applications close on January 11, 2023.